Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04416984
Brief Title: Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma (ALPHA-2) (ALPHA-2)

First Submitted : May 29, 2020
First Submitted that Met QC Criteria : June 2, 2020
First Posted : June 4, 2020

Last Update Submitted that Met QC Criteria : October 13, 2021
Last Update Posted : October 14, 2021